February Clinical Considerations for NPs, Pas In our February Clinical Considerations, we take a look at treatment options for a few common skin disorders. New hope for eczema February 01, 2017 By Lisette Hilton The US Food and Drug Administration (FDA) has announced its approval of a new, corticoid-sparing ointment to treat mild to moderate atopic dermatitis in pediatric patients aged 2 years and older. New guidelines for early peanut exposure February 01, 2017 By Lisette Hilton New recommendations for infant exposure to peanuts to prevent peanut allergy address something many pediatricians have long suspected: Early exposure to peanuts, even in infants that have eczema, could prevent development of peanut allergy. Guidelines recommend early peanut introduction January 25, 2017 By Lisette Hilton Experts weigh in on what to know about the new addendum to the peanut allergy prevention guidelines. January Clinical Considerations for NPs, PAs This month, we take a look at when to use biologics, advances in pediatric Atopic Dermatitis (AD), and how Trump’s presidency might impact dermatology. Research suggests new approaches to treat AD Research aimed at understanding the host-microbial interface in atopic dermatitis is ongoing but already providing insights for novel therapeutic strategies. Dermatology’s 2017 Game Changers December 19, 2016 By Lisette Hilton Several dermatologists go over what they're most excited about to see in 2017 in a number of different topics ranging from AD treatment to off-label technology use, to more male patients. December Clinical Considerations for NPs, PAs In this month's Clinical Considerations, we take a look at AD and bullying, whether or not derms are doing enough for psoriasis patients, and the potential of Epicutaneous immunotherapy. Novel immunomodulators expected to usher in new therapeutic era A number of systemic and topical treatments for atopic dermatitis are being developed that feature novel mechanisms of action targeting the inflammatory axes involved in the disease. Study offers new insight into pediatric eczema December 02, 2016 By Lisette Hilton Researchers have identified the skin phenotype of pediatric atopic dermatitis (AD) — a finding that challenges the notion of filaggrin's central role in the disease.